The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
Open accessAbstract
Aberrant promoter hypermethylation or histone modifications are recognized as an important mechanism in cancer initiation and progression.1 These epigenetic mechanisms are recognized as a "third pathway" in Knudson's model of tumorsuppressor gene inactivation and can affect gene expression without accompanying genetic changes. 2 DNA methylation occurs in the cytosine-guanine sequence (CpG) in mammalian DNA strands.The pattern of methylation at cytosine residues in the CpG sequences is established during early development and is heritable.3 In humans, approximately 70% of CpG dinucleotides are methylated.The frequency of the CpG dinucleotide is relatively low in most of the human genome because of CG suppression.However, genomic sequencing reveals that CpG sites are unevenly distributed in the mammalian genome.About 60% of genes have 5' promoter regions located in the CpG rich 0.3-2 kb stretches of DNA called CpG islands.CpG islands are normally unmethylated.4,5 Promoter associated CpG islands need to be protected against DNA hypermethylation that results in irreversible inhibition of gene expression.In normal cells, this is evidenced by methylation associated silencing of imprinted genes and inactive X chromosome genes.In cancers, this mechanism is utilized to inactivate tumor-suppressor genes.6 Histone modification is another key mechanism in transcriptional regulation, which is well conserved through a variety of species.[7][8][9] The less structured Nterminal domains of all core histones protrude from the core histone and are subject to chemical modifications, such as acetylation, methylation, and phosphorylation at certain residues.10,11 The modification patterns of histone have been linked to
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Signaling to Chromatin through Histone Modifications
Cheung, P., Allis, C. D., & Sassone-Corsi, P. (2000) · Cell · doi:10.1016/s0092-8674(00)00118-5 · Cited by 989
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957
van der Vlag, J., & Otte, A. P. (1999) · Nature Genetics · doi:10.1038/70602 · Cited by 527
Robertson, K. D., & Jones, P. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6457 · Cited by 352
Cited by
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01150 · Cited by 472
Modern epigenetics methods in biological research
Li, Y. (2021) · Methods · doi:10.1016/j.ymeth.2020.06.022 · Cited by 339
Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes
Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., & Leung, Y.-K. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.289 · Cited by 312
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases
Paul, B., Barnes, S., Demark-Wahnefried, W., Morrow, C., Salvador, C., Skibola, C., & Tollefsbol, T. O. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0144-7 · Cited by 306
Epigenetics meets endocrinology
Zhang, X., & Ho, S.-M. (2011) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0053 · Cited by 298
Metadata
- Authors
- Kondo, Y.
- Venue
- Yonsei Medical Journal
- Publisher
- XMLink
- Published
- 2009
- Volume
- 50
- Issue
- 4
- Pages
- 455
- ISSN
- 0513-5796 (ISSN-L)
- OpenAlex
- W2154719999
- Cited by
- 223
- References
- 11
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.